BAP Pharma are honoured to receive an award from FEBE Growth 100 and to have been ranked within the 2022 list of the fastest growing, founder-led, privately-owned UK businesses.

BAP Pharma receiving the FEBE Growth 100 Award – pictured left to right – Award Partner Anthony Higson from Pictet, FEBE Founder John Maffioli, BAP Pharma Founder Dr. Bashir Parkar and FEBE Ambassador Brian McRitchie.

FEBE (For Entrepreneurs, By Entrepreneurs) has set out to champion, inspire and celebrate the very best entrepreneurs and their companies.

Introduced in 2022, the annual FEBE Growth 100 list contains the top 100 fastest-growing, UK based, privately-owned, founder-led companies, which are ranked by their CAGR (Compound Annual Growth Rate) in sales over the latest two financial years.

With 4.2 million privately owned companies based in the UK and just 1% of those companies considered as ‘High-Growth – BAP Pharma’s ranking is a great representation of the dedication and efforts of our teams across the world.

“We are proud to have been recognised in the FEBE Growth 100 list as recognition of our continued success and growth over the years, which has facilitated the expansion of operations internationally and enabled us to continue to deliver on our promises and provide our clients with customer service excellence.

I would like to thank the support and loyalty of our customers and the efforts of our amazing teams across the world”

Dr. Bashir Pakar, Founder and Managing Director of BAP Pharma.